Frank Striggow

Title: Frank Striggow: Innovator in Neurodegenerative Disease Research

Introduction

Frank Striggow is a notable inventor based in Gerwisch, Germany. He has made significant contributions to the field of neurodegenerative disease research, holding a total of 6 patents. His work focuses on innovative methods and devices that enhance the understanding and treatment of complex medical conditions.

Latest Patents

One of Striggow's latest patents is a device and method for measuring impedance in organotypic tissues. This invention involves a device that includes a recording chamber with a liquid permeable membrane supporting organotypic tissue. The device features electrodes that measure impedance, allowing researchers to analyze the effects of test compounds on both pathological and non-pathological organotypic tissues. Another significant patent involves polymutant tau protein variants, which are used to recapitulate human tauopathies. This invention aims to identify agents for treating or preventing neurodegenerative diseases, particularly those linked to frontotemporal dementia and parkinsonism.

Career Highlights

Throughout his career, Frank Striggow has worked with various companies, including Keyneurotek Pharmaceuticals AG and Key Neurotek AG. His innovative approaches have positioned him as a key figure in the development of new therapeutic strategies for neurodegenerative diseases.

Collaborations

Striggow has collaborated with notable professionals in his field, including Till Mack and Siegfried Ansorge. These partnerships have furthered his research and contributed to the advancement of neurodegenerative disease treatments.

Conclusion

Frank Striggow's contributions to the field of neurodegenerative disease research through his patents and collaborations highlight his role as an influential inventor. His innovative devices and methods continue to pave the way for advancements in medical science.